P. Borrow, H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone, Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection, J Virol, vol.68, pp.6103-6110, 1994.

X. Jin, T Cell Depletion in Simian Immunodeficiency Virus???infected Macaques, The Journal of Experimental Medicine, vol.41, issue.6, pp.991-998, 1999.
DOI : 10.1007/BF00918085

P. Kiepiela, CD8+ T-cell responses to different HIV proteins have discordant associations with viral load, Nature Medicine, vol.53, issue.1, pp.46-53, 2007.
DOI : 10.1038/nm1520

J. Martinez-picado, Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.80, issue.7, pp.3617-3623, 2006.
DOI : 10.1128/JVI.80.7.3617-3623.2006

C. E. Mackewicz, H. W. Ortega, and J. A. Levy, CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual., Journal of Clinical Investigation, vol.87, issue.4, pp.1462-1466, 1991.
DOI : 10.1172/JCI115153

H. Tsubota, C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin, A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes, Journal of Experimental Medicine, vol.169, issue.4
DOI : 10.1084/jem.169.4.1421

O. O. Yang, Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms, J Virol, vol.71, pp.3120-3128, 1997.

B. D. Walker and D. R. Burton, Toward an AIDS Vaccine, Science, vol.6, issue.2, pp.760-764, 2008.
DOI : 10.1038/nrmicro1819

V. Appay, D. C. Douek, and D. A. Price, CD8+ T cell efficacy in vaccination and disease, Nature Medicine, vol.205, issue.6, pp.623-628, 2008.
DOI : 10.1038/nm.f.1774

D. Souza, M. P. Altfeld, and M. , Measuring HIV-1-specific T cell immunity: how valid are current assays?, J Infect Dis, vol.197, pp.337-339, 2008.

S. G. Deeks and B. Walker, Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.
DOI : 10.1016/j.immuni.2007.08.010

O. Connell, K. A. Bailey, J. R. Blankson, and J. N. , Elucidating the elite: mechanisms of control in HIV-1 infection, Trends in Pharmacological Sciences, vol.30, issue.12, pp.631-637, 2009.
DOI : 10.1016/j.tips.2009.09.005

A. Saez-cirion, G. Pancino, M. Sinet, A. Venet, and O. Lambotte, HIV controllers: how do they tame the virus?, Trends in Immunology, vol.28, issue.12, pp.532-540, 2007.
DOI : 10.1016/j.it.2007.09.002

J. C. Gea-banacloche, Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors, The Journal of Immunology, vol.165, issue.2, pp.1082-1092, 2000.
DOI : 10.4049/jimmunol.165.2.1082

A. Saez-cirion, Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses, The Journal of Immunology, vol.182, issue.12, pp.7828-7837, 2009.
DOI : 10.4049/jimmunol.0803928

B. M. Baker, B. L. Block, A. C. Rothchild, and B. D. Walker, Elite control of HIV infection: implications for vaccine design, Expert Opinion on Biological Therapy, vol.449, issue.1, pp.55-69, 2009.
DOI : 10.1097/QAD.0b013e3282f470e4

M. R. Betts, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006.
DOI : 10.1182/blood-2005-12-4818
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895811

S. A. Migueles, HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002.
DOI : 10.1038/ni845

S. A. Migueles, Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control, Immunity, vol.29, issue.6, pp.1009-1021, 2008.
DOI : 10.1016/j.immuni.2008.10.010

A. Sáez-cirión, HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.1, issue.4, pp.6776-6781, 2007.
DOI : 10.1128/JVI.77.4.2550-2558.2003

S. A. Migueles, Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy, Journal of Virology, vol.83, issue.22, pp.11876-11889, 2009.
DOI : 10.1128/JVI.01153-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772718

L. Vojnov, Effective Simian Immunodeficiency Virus-Specific CD8+ T Cells Lack an Easily Detectable, Shared Characteristic, Journal of Virology, vol.84, issue.2, pp.753-764, 2010.
DOI : 10.1128/JVI.01596-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798340

J. B. Sacha, Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression, The Journal of Immunology, vol.178, issue.5, pp.2746-2754, 2007.
DOI : 10.4049/jimmunol.178.5.2746
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520734/

J. R. Almeida, Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity, Blood, vol.113, issue.25, pp.6351-6360, 2009.
DOI : 10.1182/blood-2009-02-206557
URL : https://hal.archives-ouvertes.fr/inserm-00668485

H. Streeck, N. Frahm, and B. D. Walker, The role of IFN-?? Elispot assay in HIV vaccine research, Nature Protocols, vol.61, issue.4, pp.461-469, 2009.
DOI : 10.1186/1479-5876-3-20

A. B. Van-'t-wout, H. Schuitemaker, and N. A. Kootstra, Isolation and propagation of HIV-1 on peripheral blood mononuclear cells, Nature Protocols, vol.106, issue.3, pp.363-370, 2008.
DOI : 10.1038/nprot.2008.3